No single drug delivery partnership model can be applied across all drug delivery partnerships. Partnering around drug delivery technology can occur at different stages of the drug development and commercialization lifecycle, requiring varying levels of collaboration and involving multiple different partners and their respective interests.
The degree of intended collaboration between drug delivery technology partners has declined over the past five years. Big pharma has become an increasingly important source for high value licensing investment in novel drug delivery technologies.
This report builds on interviews with industry executives, case studies, and analysis of deal and other market data to set out a set of strategies to optimally partner for enhanced drug delivery products.
Features and benefits
Your key questions answered
View the complete report @ http://www.reportsnreports.com/reports/150506-drug-delivery-partnership-strategies.html
Released On: 9/3/2012
Views: 3191
Released On: 8/31/2012
Views: 3916
Released On: 8/27/2012
Views: 2203
Released On: 8/23/2012
Views: 3062
Released On: 8/23/2012
Views: 2104
Released On: 8/21/2012
Views: 2782
Released On: 8/16/2012
Views: 3432
Released On: 8/16/2012
Views: 2035
Released On: 8/16/2012
Views: 4278
Released On: 8/14/2012
Views: 2167
Released On: 8/14/2012
Views: 1861